ANNOVIS BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.21 USD | +2.24% |
|
+38.45% | -56.10% |
| 10/05 | Annovis Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 09/05 | Annovis Bio, Inc. Announces Unblinding of the Buntanetap Phase III Data in Parkinson?s Disease | CI |
a23c9d5a55d0ce.Law2l2qb94zhyYGEG9WolX6RytPRkLxBm_TxY7YW5sI.fPYb8QfIqPabiNLcV6OZ5gzZg7K898ts2ZuCJJtGvrBA2gLFKeuo67ex1A~21195eb51854276c2094b18a827d4f26